Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

about

Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer

P2860

Q57171137-38F4D2DA-2CF9-40A5-AC37-DA3996931F54 Q58758978-12112F8E-6B30-4856-A45C-E0EF05C00FF3

P2860

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

Item

http://www.wikidata.org/entity/Q50075685

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@en

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@nl

type

Item

label

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@en

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@nl

prefLabel

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@en

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@nl

P1476

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

@en

P2093

Melissa Bedard

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunoediting from immune surveillance to immune escape

Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents

Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials

The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude

The actin cytoskeleton modulates the activation of iNKT cells by segregating CD1d nanoclusters on antigen-presenting cells.

CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor

A Molecular Basis for the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural Killer T Cells

Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis.

P304

1829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2017.01829

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Cerundolo

Mariolina Salio

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29326711

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5741693

http://www.w3.org/2001/XMLSchema#string

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

about

P2860

P2860

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932